Prognostic Value of the Pace of Tumor Progression as Assessed by Serial <sup>18</sup>F-FDG PET/CT Scan and Liquid Biopsy in Refractory Colorectal Cancer: The CORIOLAN Trial

Prognostic Value of the Pace of Tumor Progression as Assessed by Serial <sup>18</sup>F-FDG PET/CT Scan and Liquid Biopsy in Refractory Colorectal Cancer: The CORIOLAN Trial

Introduction: Decision making in refractory colorectal cancer (rCRC) is challenging, with limited data available to predict patient outcome. We conducted a study to assess the pace of cancer progression as a potential prognostic and decision tool. Methods: CORIOLAN was a prospective, single-center,...

Full description

Bibliographic Details
Main Authors: Silvia Camera, Tugba Akin Telli, Erwin Woff, Caroline Vandeputte, Pashalina Kehagias, Thomas Guiot, Gabriela Critchi, Yacine Wissam, Giacomo Bregni, Elena Trevisi, Andrea Pretta, Chiara Senti, Sophia Leduc, Paraskevas Gkolfakis, Frédéric Hoerner, Françoise Rothé, Francesco Sclafani, Patrick Flamen, Amelie Deleporte, Alain Hendlisz
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Cancers
Subjects:
pace of progression
colorectal cancer
whole-body metabolically active tumor volume
circulating tumor DNA
circulating tumor cells
Online Access:https://www.mdpi.com/2072-6694/12/10/2752

Internet

https://www.mdpi.com/2072-6694/12/10/2752

Similar Items